Kelapher 2b 5 sterile single-dose applicators of 5 ml topical therapy

Description
Patented medical device.
Topical therapy of all trophic-dyschromic alterations of the dermo-epidermal tissue.
Post-operative bruises and hematomas (post-blepharoplasty, etc.), post-sclerotherapy hemosiderin dyschromia, prevention of iron-dependent venous ulcers, varicose ulcers, bedsores, fissures, burns, delayed wound healing, post-laser therapy (hair removal, ablative and non-ablative).

How to use
Every time the cream is applied, it is necessary to clean the affected area with saline solution. The quantity and number of applications varies depending on the clinical conditions of the lesions and the absorption time of the cream. However, at least two applications per day are recommended.

Components
Polyethylene glycol 400, polyethylene glycol 1,500, polyethylene glycol 4,000, lactoferrin LT (Lipid Technology), sorbitol, glycerol, allantoin, tocopherol.

Warnings
Do not use if the package is not intact. External use.
The simultaneous use of creams and/or similar products on the same anatomical part may affect the effectiveness and safety of the device. After use, do not dispose of the product in the environment. Keep the product out of reach of children. Do not ingest. In case of accidental ingestion, consult a doctor. Do not use beyond the expiration date.

Conservation
Store the package tightly closed at a temperature not exceeding 25 °C in a dry place, away from light and heat sources.

Format
5 sterile single-dose applicators of 5 ml.

Cod. 5010075